Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
1
9%
Ph not_applicable
9
82%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Not yet recruiting1
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (9.1%)
Phase 31 (9.1%)
N/A9 (81.8%)

Trials by Status

not_yet_recruiting19%
completed655%
terminated19%
unknown218%
enrolling_by_invitation19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11